Evidence map›Paper›PMID 25749252›Full record

ArticlePLoS genetics2015

A systems-level interrogation identifies regulators of Drosophila blood cell number and survival.

Richelle Sopko, You Bin Lin, Kalpana Makhijani, Brandy Alexander, Norbert Perrimon, Katja Brückner

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. A genome-wide survey reveals a diverse array of enhancers coordinate thebioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. eLife · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Richelle SopkoDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
You Bin LinDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, California, United States of America.
Kalpana MakhijaniDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, California, United States of America.
Brandy AlexanderDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, California, United States of America.
Norbert PerrimonDepartment of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Howard Hughes Medical Institute, Boston, Massachusetts, United States of America.
Katja BrücknerDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, California, United States of America; Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, California, United States of America; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America.
University of California, San Francisco · USHarvard University · USHoward Hughes Medical Institute · US

Funding

Tuberous Sclerosis-Pathway and PathogenesisP01CA120964 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI David J. Kwiatkowski · 2007 to 2026
$35.9M
New collections of dsRNAs and overexpression miRNA constructs to supplement RNAiR01GM067761 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI PERRIMON, NORBERT · 2003 to 2019
$15.5M
Network analysis of Signal TransductionR01DK088718 · NIDDK · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2010 to 2014
$2.5M
PROGRAM IN CRANIOFACIAL &SKELETAL BIOC06RR016490 · NCRR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BERTOLAMI, CHARLES N · 2001 to 2001
$2.0M
Regulation of cell signaling and developmental adaptation by sensory stimulationR01GM112083 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUECKNER, KATJA · 2014 to 2018
$1.5M
Mechanisms of hematopoietic regulation by the nervous systemR56HL118726 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUECKNER, KATJA · 2014 to 2014
$395k
NCI NIH HHS P01CA12096NCI NIH HHS P01 CA120964NCRR NIH HHS C06 RR016490NCRR NIH HHS C06-RR16490NHLBI NIH HHS 1R56HL118726-01A1NHLBI NIH HHS R56 HL118726NIDDK NIH HHS R01 DK088718NIDDK NIH HHS R01DK088718NIGMS NIH HHS 1R01GM112083-01NIGMS NIH HHS R01 GM067761NIGMS NIH HHS R01GM067761NIGMS NIH HHS R01 GM112083
6 · The paper itself

Abstract

In multicellular organisms, cell number is typically determined by a balance of intracellular signals that positively and negatively regulate cell survival and proliferation. Dissecting these signaling networks facilitates the understanding of normal development and tumorigenesis. Here, we study signaling by the Drosophila PDGF/VEGF Receptor (Pvr) in embryonic blood cells (hemocytes) and in the related cell line Kc as a model for the requirement of PDGF/VEGF receptors in vertebrate cell survival and proliferation. The system allows the investigation of downstream and parallel signaling networks, based on the ability of Pvr to activate Ras/Erk, Akt/TOR, and yet-uncharacterized signaling pathway/s, which redundantly mediate cell survival and contribute to proliferation. Using Kc cells, we performed a genome wide RNAi screen for regulators of cell number in a sensitized, Pvr deficient background. We identified the receptor tyrosine kinase (RTK) Insulin-like receptor (InR) as a major Pvr Enhancer, and the nuclear hormone receptors Ecdysone receptor (EcR) and ultraspiracle (usp), corresponding to mammalian Retinoid X Receptor (RXR), as Pvr Suppressors. In vivo analysis in the Drosophila embryo revealed a previously unrecognized role for EcR to promote apoptotic death of embryonic blood cells, which is balanced with pro-survival signaling by Pvr and InR. Phosphoproteomic analysis demonstrates distinct modes of cell number regulation by EcR and RTK signaling. We define common phosphorylation targets of Pvr and InR that include regulators of cell survival, and unique targets responsible for specialized receptor functions. Interestingly, our analysis reveals that the selection of phosphorylation targets by signaling receptors shows qualitative changes depending on the signaling status of the cell, which may have wide-reaching implications for other cell regulatory systems.

Indexed as

AnimalsApoptosisCell LineCell SurvivalDrosophila melanogasterDrosophila ProteinsGenome-Wide Association StudyHemocytesInsulinReceptor Protein-Tyrosine KinasesReceptors, SteroidRNA InterferenceSignal TransductionDrosophila Proteinsecdysone receptorInR protein, DrosophilaInsulinPvr protein, DrosophilaReceptor Protein-Tyrosine KinasesReceptors, Steroid

Identifiers

PMID25749252
PMCPMC4352040
OpenAlexW2124485388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.